David Andreu Martínez

Title: David Andreu Martínez: Innovator in Peptide Compounds

Introduction

David Andreu Martínez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of peptide compounds, focusing on reducing side effects associated with CB1 receptor agonists. With a total of 2 patents, his work is recognized for its therapeutic implications.

Latest Patents

Martínez's latest patents include innovative approaches to peptide compounds. One of his patents is titled "Peptide compounds for reducing side effects of CB1 receptor agonists." This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, detailing processes for their obtention and therapeutic indications. Another significant patent is the "Procedure for obtaining carbocalcitonin." This procedure involves the condensation of specific peptide fragments and the treatment of the complete peptide skeleton with an acid to free the deprotected peptide from the resin.

Career Highlights

Throughout his career, David Andreu Martínez has worked with prominent organizations such as Lipotec, S.A. and Universitat de Barcelona. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Martínez has collaborated with notable colleagues, including Marcos Canas Poblet and Berta Ponsati Obiols. These partnerships have enriched his work and fostered innovation in peptide research.

Conclusion

David Andreu Martínez stands out as an influential inventor in the field of peptide compounds. His patents and collaborations reflect his commitment to advancing therapeutic solutions. His contributions continue to impact the scientific community positively.